Characteristics of breakthrough cancer pain in patients treated with fentanyl sublingual tablets: An analysis of two phase III trials.
S. Nalamachu
Research Funding - ICRE / Multicenter Trial
R. L. Rauck
Consultant or Advisory Role - AcelRx (U); BioDelivery Sciences International (U); Prostrakan (U)
Honoraria - BioDelivery Sciences International; Prostrakan
Research Funding - AcelRx; Archimedes; BioDelivery Sciences International; Endo Pharmaceuticals; Prostrakan
A. Yellowlees
Consultant or Advisory Role - Prostrakan
M. S. Wallace
Research Funding - Endo Pharmaceuticals
D. Hassman
No relevant relationships to disclose
G. Guillory
Employment or Leadership Position - Prostrakan
J. D. Howell
Employment or Leadership Position - Prostrakan